Joseph Palumbo
Chief Tech/Sci/R&D Officer bei BIOVIE INC.
Vermögen: 3 930 $ am 31.03.2024
Profil
Joseph M.
Palumbo is currently the Director at Hydreight Technologies, Inc. and the Chief Medical Officer at BioVie, Inc. He previously worked as the Head-Global & Franchise Medical at Johnson & Johnson, Vice President-US Medical Science at Mitsubishi Tanabe Pharma Corp., and as the Chief Medical Officer & Vice President at Zynerba Pharmaceuticals, Inc. Palumbo holds an undergraduate degree from the University of Pennsylvania Graduate School of Education and a doctorate from George Washington University School of Medicine & Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOVIE INC. CLASS A
0,01% | 09.08.2023 | 7 430 ( 0,01% ) | 3 930 $ | 31.03.2024 |
Aktive Positionen von Joseph Palumbo
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOVIE INC. | Chief Tech/Sci/R&D Officer | 01.11.2021 |
| HYDREIGHT TECHNOLOGIES INC. | Director/Board Member | 25.11.2022 |
Ehemalige bekannte Positionen von Joseph Palumbo
| Unternehmen | Position | Ende |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.10.2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Joseph Palumbo
| University of Pennsylvania Graduate School of Education | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| BIOVIE INC. | Health Technology |
| HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
| Private Unternehmen | 1 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
